仁济医院新研究发现黄连素可预防结直肠腺瘤肠镜下切除后复发 - 2021年09月14日

Local medical experts have identified a type of bacteria linked with intestinal disease and colorectal cancer. The bacteria can be used as a biomarker to forecast the development of intestinal disease and the risk of cancerous growth.

Enterotoxigenic Bacteriodes fragilis (ETBF) is strongly associated with the occurrence of inflammatory bowel disease and colorectal cancer. However, the bacteria's mechanism for causing ETBF-induced intestinal problems has remained unclear.

Experts from Shanghai's Renji Hospital used microRNA (mRNA) sequencing to explain the mechanism and confirmed that ETBF and one specific mRNA can be used as biomarker to indicate treatment effects and work as treatment targets for inflammatory bowel disease and colorectal cancer.